Drugs / human immunoglobulins G
last change Jan 2008 re-read 3 minutes ago

human immunoglobulins G

Developed for
anti-neutrophil cytoplasmic antibody-associated vasculitis
Investigated by
Assistance Publique - Hôpitaux de Paris

Trials 1

200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00307658 Mar 2001 → Jul 2006 anti-neutrophil cytoplasmic antibody-associated vasculitis Assistance Publique - Hôpitaux de Paris Terminated No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as human immunoglobulins G ClinicalTrials.gov intervention name — accepted as the source's own label NCT00307658 ↗
Route Intravenous “intravenous immunoglobulins (IVIGs) administered for 6 months” PMID 18163506 ↗ Jan 2008